A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone
Clinical trial NCT06104878 · WITHDRAWN
Trial details
- NCT number
- NCT06104878
- Sponsor
- Takeda
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-31
- Primary completion
- 2024-10-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.